BIO-key Releases 2026 Financial Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2026
0mins
Source: seekingalpha
- Financial Performance: BIO-key reported a GAAP EPS of -$0.19 for Q4, with revenue of $1.24 million, reflecting a 15.1% year-over-year decline, indicating pressure in the competitive landscape.
- Preliminary Forecast: The company anticipates Q1 2026 revenue of $2.2 million, representing a 37% increase compared to Q1 2025 and an 80% increase from Q4 2025, suggesting positive signs of recovery in growth.
- Future Outlook: The outlook for 2026 indicates solid revenue growth and an improved bottom line, reflecting management's confidence in a rebound in market demand.
- Market Reaction: Despite the current financial struggles, the preliminary revenue forecast and future outlook may help bolster investor confidence and support a potential recovery in stock price.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BKYI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BKYI
About BKYI
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BIO-key International Stock Resumes Trading on Nasdaq
- Trading Resumption: BIO-key International's common stock will resume trading on the Nasdaq Capital Market at market open on July 8, 2026, marking a significant milestone in the company's compliance journey.
- Compliance Confirmation: The company confirmed compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements, following a June 16 hearing, indicating improvements in its governance structure.
- Monitoring Period Extension: BIO-key will operate under a Discretionary Panel Monitor for one year, until July 6, 2027, a measure aimed at ensuring ongoing adherence to market regulations.
- Financial Outlook: Despite reporting a GAAP EPS of -$0.15 and revenue of $2.15 million in Q1, which missed expectations, the company anticipates scaling revenue to between $5 million and $10 million in Q2, indicating potential profitability improvements.
See More
BIO-key to Participate in Jordan Cybersecurity Workshop
- Cybersecurity Workshop: BIO-key International will participate in a cybersecurity and identity workshop hosted by the Association of Banks in Jordan on July 6, gathering over 25 executives from financial institutions to address cyber threats and identity security challenges.
- Passwordless Authentication Technology: Attendees will learn how BIO-key's Identity-Bound Biometrics and PortalGuard® IAM platform enable passwordless authentication, significantly enhancing security and user experience while improving operational efficiency to meet the urgent digital transformation needs of financial institutions.
- Industry Best Practices: The workshop will focus on the current cybersecurity landscape facing financial institutions, sharing global best practices in identity verification and access management, helping attendees master cutting-edge technologies for secure passwordless user authentication.
- Strengthening Identity Security: The Association of Banks in Jordan is committed to equipping its member institutions with the knowledge and tools needed to navigate the rapidly evolving cybersecurity landscape, reflecting its ongoing efforts to enhance the resilience and digital readiness of the banking sector.
See More
BIO-key Partners with BlueAlly for Enhanced Security Solutions
- Strategic Partnership Launch: BIO-key has formed a strategic partnership with BlueAlly, successfully deploying the PortalGuard platform at AOD Federal Credit Union to eliminate user experience friction and security vulnerabilities associated with traditional Multi-Factor Authentication (MFA), thereby enhancing security for financial institutions.
- Enhanced Security: By implementing BIO-key's Identity-Bound Biometrics, AOD has effectively mitigated credential-based risks, ensuring that only authorized individuals can access the system, which meets the highest regulatory compliance standards and significantly reduces the operational burden on its IT team.
- Optimized User Experience: The CIO of AOD stated that BIO-key's solution offers flexibility beyond Duo Security and UserLock, combining biometric authentication with various MFA options to reduce risk and support a zero-trust strategy, while streamlining operations and boosting productivity.
- Significant Market Potential: BIO-key's identity and access management software secures access for over 40 million users, and as the financial sector's demand for security increases, the company's innovations in biometrics and passwordless authentication are expected to further drive its market share growth.
See More
BIO-key International Reports 34% Revenue Growth in Q1 2026
- Significant Revenue Growth: BIO-key International reported a 34% increase in Q1 2026 revenues to $2.1 million, driven by new customer acquisitions and expanded deployments, laying a solid foundation for future market expansion.
- Strong Gross Margin: The company maintained a gross margin of 82% in Q1 2026, consistent with 2025, highlighting the advantages of high-margin license fee revenue and sales of fully reserved inventory, which bolster profitability.
- Improved Net Loss: Although the net loss for Q1 2026 was $165,036, an improvement from $736,545 in Q1 2025, ongoing privacy and regulatory challenges in the U.S. market could impact future financial performance.
- Optimistic Market Outlook: BIO-key's partnership with DLT Solutions provides a streamlined procurement path for public sector customers, which is expected to enhance market penetration in defense and financial services, strengthening its long-term growth potential.
See More
BIO-key International Q1 2026 Earnings Call Insights
- Significant Revenue Growth: BIO-key International reported a 34% year-over-year revenue increase in Q1 2026, reaching $2.1 million compared to $1.6 million in Q1 2025, indicating strong performance from new customer acquisitions and long-term deployments in defense and financial services.
- Hardware Revenue Doubling: The company's hardware revenue surged over 100% to approximately $531,000, reflecting a significant increase in hardware demand as larger licensing opportunities close, thereby enhancing profit margins.
- NASDAQ Return Plan: The company is actively pursuing its NASDAQ appeal process, with a hearing scheduled for June 16, and management expresses optimism about returning to NASDAQ trading by summer, which could boost investor confidence and market recognition.
- Positive Future Outlook: Management anticipates profitability and positive cash flow in Q2, emphasizing that as revenue scales up, profits will significantly increase, indicating the company's growth potential and competitive positioning in the market.
See More
BIO-key Q1 Earnings Report Analysis
- Earnings Performance: BIO-key reported a Q1 GAAP EPS of -$0.15 with revenues of $2.15 million, reflecting a 34% year-over-year increase, yet it missed expectations by $0.05 million, indicating challenges in revenue growth.
- Future Outlook: The company anticipates a 65% revenue increase in Q2 2025 to approximately $2.8 million compared to $1.7 million in Q2 2025, showcasing confidence in future growth while needing to overcome current financial pressures.
- Profitability Expectations: BIO-key expects to achieve profitability in H1 2026 with projected revenues of $5 million, a significant turnaround from a net loss of $1.9 million in H1 2025, indicating efforts to improve financial health.
- Cash Position: The cash position for H1 2026 is expected to remain in line with the current status, and despite challenges, the company maintains an optimistic outlook for revenue growth and improved bottom line for the full year 2026.
See More
BIO-key International Stock Resumes Trading on Nasdaq
- Trading Resumption: BIO-key International's common stock will resume trading on the Nasdaq Capital Market at market open on July 8, 2026, marking a significant milestone in the company's compliance journey.
- Compliance Confirmation: The company confirmed compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements, following a June 16 hearing, indicating improvements in its governance structure.
- Monitoring Period Extension: BIO-key will operate under a Discretionary Panel Monitor for one year, until July 6, 2027, a measure aimed at ensuring ongoing adherence to market regulations.
- Financial Outlook: Despite reporting a GAAP EPS of -$0.15 and revenue of $2.15 million in Q1, which missed expectations, the company anticipates scaling revenue to between $5 million and $10 million in Q2, indicating potential profitability improvements.
See More
BIO-key to Participate in Jordan Cybersecurity Workshop
- Cybersecurity Workshop: BIO-key International will participate in a cybersecurity and identity workshop hosted by the Association of Banks in Jordan on July 6, gathering over 25 executives from financial institutions to address cyber threats and identity security challenges.
- Passwordless Authentication Technology: Attendees will learn how BIO-key's Identity-Bound Biometrics and PortalGuard® IAM platform enable passwordless authentication, significantly enhancing security and user experience while improving operational efficiency to meet the urgent digital transformation needs of financial institutions.
- Industry Best Practices: The workshop will focus on the current cybersecurity landscape facing financial institutions, sharing global best practices in identity verification and access management, helping attendees master cutting-edge technologies for secure passwordless user authentication.
- Strengthening Identity Security: The Association of Banks in Jordan is committed to equipping its member institutions with the knowledge and tools needed to navigate the rapidly evolving cybersecurity landscape, reflecting its ongoing efforts to enhance the resilience and digital readiness of the banking sector.
See More
BIO-key Partners with BlueAlly for Enhanced Security Solutions
- Strategic Partnership Launch: BIO-key has formed a strategic partnership with BlueAlly, successfully deploying the PortalGuard platform at AOD Federal Credit Union to eliminate user experience friction and security vulnerabilities associated with traditional Multi-Factor Authentication (MFA), thereby enhancing security for financial institutions.
- Enhanced Security: By implementing BIO-key's Identity-Bound Biometrics, AOD has effectively mitigated credential-based risks, ensuring that only authorized individuals can access the system, which meets the highest regulatory compliance standards and significantly reduces the operational burden on its IT team.
- Optimized User Experience: The CIO of AOD stated that BIO-key's solution offers flexibility beyond Duo Security and UserLock, combining biometric authentication with various MFA options to reduce risk and support a zero-trust strategy, while streamlining operations and boosting productivity.
- Significant Market Potential: BIO-key's identity and access management software secures access for over 40 million users, and as the financial sector's demand for security increases, the company's innovations in biometrics and passwordless authentication are expected to further drive its market share growth.
See More
BIO-key International Reports 34% Revenue Growth in Q1 2026
- Significant Revenue Growth: BIO-key International reported a 34% increase in Q1 2026 revenues to $2.1 million, driven by new customer acquisitions and expanded deployments, laying a solid foundation for future market expansion.
- Strong Gross Margin: The company maintained a gross margin of 82% in Q1 2026, consistent with 2025, highlighting the advantages of high-margin license fee revenue and sales of fully reserved inventory, which bolster profitability.
- Improved Net Loss: Although the net loss for Q1 2026 was $165,036, an improvement from $736,545 in Q1 2025, ongoing privacy and regulatory challenges in the U.S. market could impact future financial performance.
- Optimistic Market Outlook: BIO-key's partnership with DLT Solutions provides a streamlined procurement path for public sector customers, which is expected to enhance market penetration in defense and financial services, strengthening its long-term growth potential.
See More
BIO-key International Q1 2026 Earnings Call Insights
- Significant Revenue Growth: BIO-key International reported a 34% year-over-year revenue increase in Q1 2026, reaching $2.1 million compared to $1.6 million in Q1 2025, indicating strong performance from new customer acquisitions and long-term deployments in defense and financial services.
- Hardware Revenue Doubling: The company's hardware revenue surged over 100% to approximately $531,000, reflecting a significant increase in hardware demand as larger licensing opportunities close, thereby enhancing profit margins.
- NASDAQ Return Plan: The company is actively pursuing its NASDAQ appeal process, with a hearing scheduled for June 16, and management expresses optimism about returning to NASDAQ trading by summer, which could boost investor confidence and market recognition.
- Positive Future Outlook: Management anticipates profitability and positive cash flow in Q2, emphasizing that as revenue scales up, profits will significantly increase, indicating the company's growth potential and competitive positioning in the market.
See More
BIO-key Q1 Earnings Report Analysis
- Earnings Performance: BIO-key reported a Q1 GAAP EPS of -$0.15 with revenues of $2.15 million, reflecting a 34% year-over-year increase, yet it missed expectations by $0.05 million, indicating challenges in revenue growth.
- Future Outlook: The company anticipates a 65% revenue increase in Q2 2025 to approximately $2.8 million compared to $1.7 million in Q2 2025, showcasing confidence in future growth while needing to overcome current financial pressures.
- Profitability Expectations: BIO-key expects to achieve profitability in H1 2026 with projected revenues of $5 million, a significant turnaround from a net loss of $1.9 million in H1 2025, indicating efforts to improve financial health.
- Cash Position: The cash position for H1 2026 is expected to remain in line with the current status, and despite challenges, the company maintains an optimistic outlook for revenue growth and improved bottom line for the full year 2026.
See More
